Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DET1 and DDB1 associated 1 pseudogene (ENSG00000258509) is classified as a pseudogene, meaning it is a DNA sequence similar to a protein-coding gene but is generally nonfunctional due to mutations, loss of coding capability, or regulatory elements required for expression[4][2][5]. It is related by sequence homology to the functional DET1 and DDB1 associated 1 gene (DDA1), but does not encode a functional protein and is not considered a therapeutic target, receptor, enzyme, transporter, or transcription factor[5][2][4]. Pseudogenes can sometimes participate in gene regulation, but there is no published evidence that ENSG00000258509 has any regulatory, biological, or clinical function[5][4][6]. In summary, this entry represents a nonfunctional genomic relic, not a molecular target for therapy or diagnostics. If you have questions about the functional DDA1 protein (DET1-DDB1-associated 1), which is involved in ubiquitination and chromatin regulation, please specify, as that is a distinct, functional gene/protein[1][3][7].
None (not a protein, not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DET1 and DDB1 associated 1 pseudogene (ENSG00000258509).